T 0317/95 (Gastrointestinal compositions/PROCTER & GAMBLE) of 26.02.1999
- European Case Law Identifier
- ECLI:EP:BA:1999:T031795.19990226
- Date of decision
- 26 February 1999
- Case number
- T 0317/95
- Petition for review of
- -
- Application number
- 88200397.3
- IPC class
- A61K 33/24
- Language of proceedings
- English
- Distribution
- Distributed to board chairmen and members (B)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Compositions and their use for treating gastrointestinal disorders
- Applicant name
- The Procter & Gamble Company
- Opponent name
- 01: Glaxo Group Limited
02: SmithKline Beecham plc. - Board
- 3.3.02
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 52(1) 1973European Patent Convention Art 52(4) 1973European Patent Convention Art 54(1) 1973European Patent Convention Art 54(2) 1973European Patent Convention Art 54(5) 1973European Patent Convention Art 56 1973
- Keywords
- Novelty and patentability under Article 52(4) EPC: (questionable)
Inventive step: (no), obvious modification in relation to simplification and patient's compliance - Catchword
- Use claims directed to the second medical use of two known drugs - treatment by concurrent administration differing from treatment in the prior art by the prescribed regimen (see reasons No. 4).
ORDER
For these reasons it is decided that:
The appeal is dismissed.